Intracranial Aneurysm Market Projected to Hit USD 2.7 Billion by 2032

Introduction

The global Intracranial Aneurysm market, valued at USD 1.2 billion in 2022, is projected to reach USD 2.7 billion by 2032, exhibiting a CAGR of 8.8% during the forecast period. This growth is primarily fueled by advancements in medical imaging and minimally invasive surgical techniques, enhancing early diagnosis and treatment effectiveness. These technological developments are pivotal in reducing rupture risks and improving patient outcomes, promising continued market expansion.

Increased awareness of intracranial aneurysm risk factors, such as hypertension and smoking, has also catalyzed market growth. Enhanced public knowledge has led to more proactive screening, particularly among high-risk individuals, elevating diagnosis rates and subsequently boosting demand for treatment options. Further, research into the genetic basis of these aneurysms is deepening understanding of familial risks, aiding in the development of targeted prevention and treatment strategies.

The market is further supported by a growing geriatric population prone to aneurysms and rising global healthcare expenditures. As healthcare accessibility improves, there is an increasing demand for sophisticated treatment options, sustaining market growth. This demographic shift, coupled with ongoing innovations in medical devices, is set to maintain the market’s upward trajectory over the next decade.

Recent developments within the market include significant contributions from leading companies. For instance, in July 2024, MicroPort NeuroTech™ launched the first application of its innovative PCAR Intervention System, potentially revolutionizing neurovascular condition management. Additionally, in April 2024, Integra LifeSciences reintroduced the CereLink® Intracranial Pressure Monitoring System in the U.S., emphasizing its clinical relevance at the American Association of Neurological Surgeons Annual Meeting.

Moreover, Medtronic PLC’s recent FDA approval of the PulseSelect™ pulsed field ablation system and the Percept™ RC neurostimulator in February 2024 exemplifies ongoing commitments to medical innovation. These developments not only highlight a period of dynamic technological advancement but also reflect significant investment aimed at enhancing neurovascular and intracranial health outcomes. The integration of sophisticated monitoring systems and new treatment modalities is expected to drive substantial growth in the intracranial aneurysm treatment landscape.

Key Takeaways

• Market Growth: The market is expected to grow from USD 1.2 billion in 2022 to USD 2.7 billion by 2032, with an 8.8% CAGR from 2023 to 2032.
• By Type: Endovascular coiling holds the highest revenue share, offering advantages like easy access and quicker recovery.
• Flow Diverters’ CAGR: Flow diverters are projected to have the highest CAGR, driven by increased product approvals and demand for minimally invasive procedures.
• Based on End User: Hospitals lead in market revenue due to advanced technology, patient preference, and government funding.
• Market Drivers: The market is driven by the growing prevalence of brain aneurysms, an aging population, and rising disease awareness.
• Regional Leadership: North America dominates the market with advanced healthcare facilities, while the Asia Pacific region is expected to have the highest CAGR.
• Prominent Players: Key players include Medtronic, Stryker, Johnson & Johnson, Braun, and others.

Intracranial Aneurysm Statistics

Number of People Affected

• An estimated 6.7 million people in the U.S. have an unruptured brain aneurysm, or 1 in 50 people.
• The annual rupture rate is approximately 8–10 per 100,000 people.
• About 30,000 people in the U.S. suffer a brain aneurysm rupture each year, with one rupture occurring every 18 minutes.
• Nearly 500,000 deaths occur worldwide annually due to brain aneurysms, with half of the victims being younger than 50.
• Brain aneurysms affect an estimated 3–5% of people in the U.S. during their lifetime, being more common in females and affecting adults aged 30–60.

Population Most Affected

• Brain aneurysms are most common in people aged 35 to 60 but can occur in children.
• Most aneurysms develop after the age of 40, with a median occurrence age of 50.
• Women are more likely to have brain aneurysms than men, with a ratio of 3:2.
• Women over 55 have a 1.5 times higher risk of aneurysm rupture compared to men.
• African-Americans and Hispanics are about twice as likely to have an aneurysm rupture compared to Caucasians.
• Hispanic-Americans and African-Americans have a 25% higher risk of developing a brain aneurysm.

Devastation Caused by Aneurysms

• Ruptured brain aneurysms are fatal in about 50% of cases; 66% of survivors suffer permanent neurological deficits.
• Approximately 15% of those with a ruptured aneurysm die before reaching the hospital, with 25% dying within 24 hours.
• 75% of brain aneurysm ruptures result in death or permanent disability.
• Nearly 5% of severe headache-related emergency room admissions are due to ruptured aneurysms.
• Cerebral aneurysms cause almost 500,000 deaths worldwide each year, with women and those under 50 at greater risk.
• Over 50% of aneurysm-related deaths are due to subarachnoid hemorrhage, the most dangerous type of stroke.

Diagnosis and Treatment Facts

• Most aneurysms are small, ranging from 1/8 inch to nearly one inch.
• 20% of people diagnosed with a brain aneurysm have more than one aneurysm.
• Aneurysms larger than one inch, known as “giant” aneurysms, pose a particularly high risk and are harder to treat.
• Ruptured brain aneurysms account for 3-5% of all new strokes.
• Among patients with severe headaches, approximately 1-4% have a ruptured aneurysm.
• Individuals with asymmetric brain arteries have a significantly higher risk of developing aneurysms in the affected region.

Misdiagnosis and Associated Costs

• Misdiagnosis or delayed diagnosis occurs in up to 25% of patients with ruptured brain aneurysms, often due to the failure to perform a scan.
• Treatment costs increase significantly after an aneurysm ruptures, with surgical clipping costs more than doubling and endovascular coiling costs rising by about 70%.
• The federal government spends only $2.08 per year on brain aneurysm research for each afflicted person.
• Hospital costs for clipping or coiling treatments can reach $50,000 or more.

Emerging Trends

• Minimally Invasive Techniques: The shift towards minimally invasive methods, like endovascular coiling and flow diversion, marks a significant trend. These procedures reduce the time needed for recovery and enhance overall patient outcomes. By minimizing surgical invasiveness, they provide a less stressful healing process and quicker return to daily activities.
• Advances in Imaging Technology: Technological advancements in imaging, such as 3D rotational angiography and high-resolution MRI, are revolutionizing the detection and diagnosis of intracranial aneurysms. These improved imaging methods enable earlier and more precise interventions, significantly enhancing treatment accuracy.
• Increased Genetic Research: Research focusing on the genetic causes of aneurysms is evolving, paving the way for personalized treatment plans. This is particularly beneficial for patients with a familial predisposition to aneurysms, as it allows for tailored preventive and therapeutic strategies based on individual genetic profiles.
• Integration of Artificial Intelligence (AI): Artificial intelligence is becoming integral in the realm of aneurysm diagnostics, assisting in more accurate aneurysm detection and risk assessment of potential ruptures. AI’s predictive capabilities are instrumental in refining treatment planning and decision-making processes.
• Development of New Stents and Flow Diverters: Recent innovations in the design of stents and flow diverters are enhancing treatment safety and effectiveness. These advancements are crucial for managing complex or large aneurysms, which previously posed significant challenges in treatment.
• Focus on Preventative Care: There is a growing emphasis on preventative measures and managing risk factors, such as blood pressure control and smoking cessation. Such strategies are vital in decreasing the likelihood of developing aneurysms and preventing potential ruptures.
• Telemedicine and Remote Monitoring: The use of telemedicine and remote monitoring technologies is expanding, especially valuable in areas with limited access to specialized medical care. These tools allow for ongoing patient management and follow-up care from a distance, enhancing patient engagement and monitoring.
• Patient-Centric Treatment Approaches: The trend towards personalized medicine is accelerating, with treatments increasingly tailored to each patient’s specific health needs and aneurysm characteristics. This patient-centric approach allows for more precise and effective management of the condition.

Use Cases

• Early Detection through Advanced Imaging: The advancement of imaging technologies, such as MRI and CT scans, is enhancing early detection of intracranial aneurysms. These advanced tools allow healthcare professionals to identify aneurysms before they rupture, significantly reducing the associated risks. Early detection improves patient outcomes by allowing for timely interventions and more effective treatment strategies. The use of these techniques has become a cornerstone in modern medical practices, ensuring that patients receive the care they need before complications arise.
• Minimally Invasive Treatments: Innovations in minimally invasive procedures, like endovascular coiling and flow diverter implants, are revolutionizing the treatment of intracranial aneurysms. These techniques have made it possible to treat aneurysms with less risk, fewer complications, and shorter recovery times compared to traditional methods. As a result, patients experience better outcomes, and the overall burden on healthcare systems is reduced. Minimally invasive treatments are now becoming the preferred approach for managing these life-threatening conditions.
• Proactive Screening in High-Risk Populations: With greater awareness of risk factors such as hypertension and smoking, proactive screening for intracranial aneurysms is on the rise, particularly in high-risk populations. This shift has led to earlier diagnosis and more timely treatment, which significantly improves patient outcomes. By identifying aneurysms before they cause harm, healthcare providers can offer preventive measures and reduce the likelihood of complications. Proactive screening is a critical component in managing the growing incidence of aneurysms.
• Genetic Research and Family Screening: Ongoing genetic research is shedding light on the hereditary aspects of intracranial aneurysms, enabling targeted screening for families at higher risk. This research is helping to identify genetic markers associated with aneurysm development, allowing for preventive measures to be taken. Family screening programs are now being implemented to catch aneurysms early, reducing the potential for catastrophic outcomes. This personalized approach is a promising step forward in the fight against intracranial aneurysms.
• Geriatric Care: As the global population ages, the incidence of intracranial aneurysms is expected to increase, particularly among older adults. This demographic shift necessitates specialized care and treatment options tailored to the unique needs of the elderly. Geriatric care for aneurysm patients focuses on managing comorbidities, ensuring safe treatment, and improving quality of life. Addressing the needs of this growing population is becoming a priority for healthcare providers worldwide.
• Public Health Initiatives: Government-led public health initiatives are playing a vital role in preventing intracranial aneurysms. Efforts to reduce smoking rates and manage hypertension are helping to decrease the formation and rupture of aneurysms. These initiatives not only save lives but also reduce healthcare costs and improve the overall quality of life for many individuals. Public health campaigns are proving to be effective tools in combating the risk factors associated with aneurysms.
• Emergency Care Improvements: Improvements in emergency care protocols for managing ruptured intracranial aneurysms have led to better survival rates and reduced long-term disabilities. Rapid surgical intervention and advanced critical care are crucial components of these enhanced protocols. By responding quickly and effectively, healthcare providers can significantly improve outcomes for patients experiencing aneurysm ruptures. These advancements are making a profound difference in emergency settings, where every second counts.

Conclusion

The Intracranial Aneurysm Market is poised for substantial growth, driven by advancements in medical technology, increased awareness of risk factors, and ongoing research into genetic components. Innovations in imaging and minimally invasive treatments have significantly improved the management of intracranial aneurysms, leading to better patient outcomes. Additionally, the aging global population and enhanced healthcare accessibility are expected to further boost market demand. Leading companies are continuously developing safer and more effective medical devices, while government initiatives and public health campaigns are contributing to early detection and prevention. As the market evolves, these factors will continue to play a crucial role in expanding the scope and effectiveness of aneurysm treatment and care​.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF